April 6, 2022
  • A recent Kaiser Family Foundation (KFF) poll revealed that most Americans remain concerned about out-of-pocket costs and the quality of long-term care. According to the poll, 61 percent of the public, regardless of partisanship, wants lawmakers to limit how much drug companies can increase the price of prescription drugs to not surpass inflation. Capping out-of-pocket costs for insulin and general costs for seniors were also listed as top priorities for slightly over 50 percent of respondents. Half of adults have skipped care due to costs in the past year. Dental services were the most put off, followed by vision and general care. Many in low-income households have also skipped out on prescriptions or doses. (Report here)